blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2970921

EP2970921 - HISTIDYL-TRNA SYNTHETASE-FC CONJUGATES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  26.07.2019
Database last updated on 28.06.2024
FormerThe patent has been granted
Status updated on  17.08.2018
FormerGrant of patent is intended
Status updated on  03.04.2018
FormerExamination is in progress
Status updated on  25.01.2017
Most recent event   Tooltip01.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 03.08.2022  [2022/31]
Applicant(s)For all designated states
aTyr Pharma, Inc.
3545 John Hopkins Court, Suite 250
San Diego, CA 92121 / US
[2016/03]
Inventor(s)01 / BUECHLER, Ying
1343 Cassins Street
Carlsbad, CA 92011 / US
02 / CHIANG, Kyle
1615 Debann Road
Cardiff, CA 92007 / US
03 / DO, Minh-Ha
3911 Zanako Street
San Diego, CA 92122 / US
04 / LEE, Darin
3432 Conrad Avenue
San Diego, CA 92117 / US
05 / PIEHL, Kristi
5321 Zion Avenue
San Diego, CA 92130 / US
06 / THOMAS, Marc
800 Orca Avo Drive
Vista, CA 92084-0282 / US
07 / WATKINS, Jeffry, D
3442 Fortuna Ranch Road
Encinitas, CA 92024 / US
08 / WU, Chi-Fang
2649 Villas Way
San Diego, CA 92108 / US
09 / MENDLEIN, John, D.
1550 Neptune Avenue
Encinitas, CA 92024 / US
 [2016/03]
Representative(s)Høiberg P/S
Adelgade 12
1304 Copenhagen K / DK
[2018/38]
Former [2016/03]Høiberg A/S
St. Kongensgade 59 A
1264 Copenhagen K / DK
Application number, filing date14727652.114.03.2014
[2016/03]
WO2014US29699
Priority number, dateUS201361789011P15.03.2013         Original published format: US 201361789011 P
[2016/03]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2014145050
Date:18.09.2014
Language:EN
[2014/38]
Type: A1 Application with search report 
No.:EP2970921
Date:20.01.2016
Language:EN
The application published by WIPO in one of the EPO official languages on 18.09.2014 takes the place of the publication of the European patent application.
[2016/03]
Type: B1 Patent specification 
No.:EP2970921
Date:19.09.2018
Language:EN
[2018/38]
Search report(s)International search report - published on:EP18.09.2014
ClassificationIPC:C12N9/00, C12N9/96, A61P21/00, A61P29/00
[2016/03]
CPC:
C12N9/93 (EP,US); A61P11/00 (EP,US); A61P29/00 (EP,US);
A61P37/00 (EP,US); C12N9/96 (EP,US); C12Y601/01021 (US);
C07K2319/30 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/03]
Extension statesBA15.10.2015
ME15.10.2015
TitleGerman:HISTIDYL-TRNA-SYNTHETASE-FC-KONJUGATE[2016/03]
English:HISTIDYL-TRNA SYNTHETASE-FC CONJUGATES[2016/03]
French:CONJUGUÉS HISTIDYL-ARNT SYNTHÉTASE-RÉGION FC[2016/03]
Entry into regional phase15.10.2015National basic fee paid 
15.10.2015Designation fee(s) paid 
15.10.2015Examination fee paid 
Examination procedure15.10.2015Examination requested  [2016/03]
15.04.2016Amendment by applicant (claims and/or description)
29.09.2016Despatch of a communication from the examining division (Time limit: M04)
25.01.2017Reply to a communication from the examining division
27.03.2017Despatch of a communication from the examining division (Time limit: M06)
02.10.2017Reply to a communication from the examining division
12.12.2017Despatch of a communication from the examining division (Time limit: M02)
30.01.2018Reply to a communication from the examining division
04.04.2018Communication of intention to grant the patent
02.08.2018Fee for grant paid
02.08.2018Fee for publishing/printing paid
02.08.2018Receipt of the translation of the claim(s)
Divisional application(s)EP18194251.7  / EP3460054
EP20202708.2   Application withdrawn  : 02.02.2021
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  29.09.2016
Opposition(s)20.06.2019No opposition filed within time limit [2019/35]
Fees paidRenewal fee
31.03.2016Renewal fee patent year 03
27.03.2017Renewal fee patent year 04
27.03.2018Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU14.03.2014
AL19.09.2018
AT19.09.2018
CY19.09.2018
CZ19.09.2018
EE19.09.2018
FI19.09.2018
HR19.09.2018
LT19.09.2018
LV19.09.2018
MC19.09.2018
MK19.09.2018
NL19.09.2018
PL19.09.2018
RO19.09.2018
RS19.09.2018
SE19.09.2018
SI19.09.2018
SK19.09.2018
SM19.09.2018
TR19.09.2018
BG19.12.2018
NO19.12.2018
GR20.12.2018
IS19.01.2019
PT19.01.2019
IE14.03.2019
LU14.03.2019
MT14.03.2019
BE31.03.2019
[2022/31]
Former [2021/32]HU14.03.2014
AL19.09.2018
AT19.09.2018
CY19.09.2018
CZ19.09.2018
EE19.09.2018
FI19.09.2018
HR19.09.2018
LT19.09.2018
LV19.09.2018
MC19.09.2018
NL19.09.2018
PL19.09.2018
RO19.09.2018
RS19.09.2018
SE19.09.2018
SI19.09.2018
SK19.09.2018
SM19.09.2018
TR19.09.2018
BG19.12.2018
NO19.12.2018
GR20.12.2018
IS19.01.2019
PT19.01.2019
IE14.03.2019
LU14.03.2019
MT14.03.2019
BE31.03.2019
Former [2021/26]AL19.09.2018
AT19.09.2018
CY19.09.2018
CZ19.09.2018
EE19.09.2018
FI19.09.2018
HR19.09.2018
LT19.09.2018
LV19.09.2018
MC19.09.2018
NL19.09.2018
PL19.09.2018
RO19.09.2018
RS19.09.2018
SE19.09.2018
SI19.09.2018
SK19.09.2018
SM19.09.2018
TR19.09.2018
BG19.12.2018
NO19.12.2018
GR20.12.2018
IS19.01.2019
PT19.01.2019
IE14.03.2019
LU14.03.2019
MT14.03.2019
BE31.03.2019
Former [2020/29]AL19.09.2018
AT19.09.2018
CZ19.09.2018
EE19.09.2018
FI19.09.2018
HR19.09.2018
LT19.09.2018
LV19.09.2018
MC19.09.2018
NL19.09.2018
PL19.09.2018
RO19.09.2018
RS19.09.2018
SE19.09.2018
SI19.09.2018
SK19.09.2018
SM19.09.2018
TR19.09.2018
BG19.12.2018
NO19.12.2018
GR20.12.2018
IS19.01.2019
PT19.01.2019
IE14.03.2019
LU14.03.2019
MT14.03.2019
BE31.03.2019
Former [2020/17]AL19.09.2018
AT19.09.2018
CZ19.09.2018
EE19.09.2018
FI19.09.2018
HR19.09.2018
LT19.09.2018
LV19.09.2018
MC19.09.2018
NL19.09.2018
PL19.09.2018
RO19.09.2018
RS19.09.2018
SE19.09.2018
SI19.09.2018
SK19.09.2018
SM19.09.2018
TR19.09.2018
BG19.12.2018
NO19.12.2018
GR20.12.2018
IS19.01.2019
PT19.01.2019
IE14.03.2019
LU14.03.2019
BE31.03.2019
Former [2020/12]AL19.09.2018
AT19.09.2018
CZ19.09.2018
EE19.09.2018
FI19.09.2018
HR19.09.2018
LT19.09.2018
LV19.09.2018
MC19.09.2018
NL19.09.2018
PL19.09.2018
RO19.09.2018
RS19.09.2018
SE19.09.2018
SI19.09.2018
SK19.09.2018
SM19.09.2018
BG19.12.2018
NO19.12.2018
GR20.12.2018
IS19.01.2019
PT19.01.2019
IE14.03.2019
LU14.03.2019
BE31.03.2019
Former [2020/09]AL19.09.2018
AT19.09.2018
CZ19.09.2018
EE19.09.2018
FI19.09.2018
HR19.09.2018
LT19.09.2018
LV19.09.2018
MC19.09.2018
NL19.09.2018
PL19.09.2018
RO19.09.2018
RS19.09.2018
SE19.09.2018
SI19.09.2018
SK19.09.2018
SM19.09.2018
BG19.12.2018
NO19.12.2018
GR20.12.2018
IS19.01.2019
PT19.01.2019
IE14.03.2019
LU14.03.2019
Former [2020/01]AL19.09.2018
AT19.09.2018
CZ19.09.2018
EE19.09.2018
FI19.09.2018
HR19.09.2018
LT19.09.2018
LV19.09.2018
MC19.09.2018
NL19.09.2018
PL19.09.2018
RO19.09.2018
RS19.09.2018
SE19.09.2018
SI19.09.2018
SK19.09.2018
SM19.09.2018
BG19.12.2018
NO19.12.2018
GR20.12.2018
IS19.01.2019
PT19.01.2019
LU14.03.2019
Former [2019/50]AL19.09.2018
AT19.09.2018
CZ19.09.2018
EE19.09.2018
FI19.09.2018
HR19.09.2018
LT19.09.2018
LV19.09.2018
MC19.09.2018
NL19.09.2018
PL19.09.2018
RO19.09.2018
RS19.09.2018
SE19.09.2018
SI19.09.2018
SK19.09.2018
SM19.09.2018
BG19.12.2018
NO19.12.2018
GR20.12.2018
IS19.01.2019
PT19.01.2019
Former [2019/46]AL19.09.2018
AT19.09.2018
CZ19.09.2018
EE19.09.2018
FI19.09.2018
HR19.09.2018
LT19.09.2018
LV19.09.2018
MC19.09.2018
NL19.09.2018
PL19.09.2018
RO19.09.2018
RS19.09.2018
SE19.09.2018
SK19.09.2018
SM19.09.2018
BG19.12.2018
NO19.12.2018
GR20.12.2018
IS19.01.2019
PT19.01.2019
Former [2019/26]AL19.09.2018
AT19.09.2018
CZ19.09.2018
EE19.09.2018
FI19.09.2018
HR19.09.2018
LT19.09.2018
LV19.09.2018
NL19.09.2018
PL19.09.2018
RO19.09.2018
RS19.09.2018
SE19.09.2018
SK19.09.2018
SM19.09.2018
BG19.12.2018
NO19.12.2018
GR20.12.2018
IS19.01.2019
PT19.01.2019
Former [2019/23]AL19.09.2018
AT19.09.2018
CZ19.09.2018
EE19.09.2018
FI19.09.2018
HR19.09.2018
LT19.09.2018
LV19.09.2018
NL19.09.2018
PL19.09.2018
RO19.09.2018
RS19.09.2018
SE19.09.2018
SK19.09.2018
BG19.12.2018
NO19.12.2018
GR20.12.2018
IS19.01.2019
Former [2019/22]AL19.09.2018
CZ19.09.2018
FI19.09.2018
HR19.09.2018
LT19.09.2018
LV19.09.2018
NL19.09.2018
PL19.09.2018
RO19.09.2018
RS19.09.2018
SE19.09.2018
BG19.12.2018
NO19.12.2018
GR20.12.2018
IS19.01.2019
Former [2019/21]AL19.09.2018
FI19.09.2018
HR19.09.2018
LT19.09.2018
LV19.09.2018
NL19.09.2018
RS19.09.2018
SE19.09.2018
BG19.12.2018
NO19.12.2018
GR20.12.2018
IS19.01.2019
Former [2019/20]AL19.09.2018
FI19.09.2018
HR19.09.2018
LT19.09.2018
LV19.09.2018
NL19.09.2018
RS19.09.2018
SE19.09.2018
BG19.12.2018
NO19.12.2018
GR20.12.2018
Former [2019/12]AL19.09.2018
FI19.09.2018
HR19.09.2018
LT19.09.2018
LV19.09.2018
RS19.09.2018
SE19.09.2018
BG19.12.2018
NO19.12.2018
GR20.12.2018
Former [2019/11]FI19.09.2018
HR19.09.2018
LT19.09.2018
RS19.09.2018
SE19.09.2018
BG19.12.2018
NO19.12.2018
GR20.12.2018
Former [2019/10]FI19.09.2018
LT19.09.2018
RS19.09.2018
SE19.09.2018
BG19.12.2018
NO19.12.2018
GR20.12.2018
Former [2019/08]FI19.09.2018
LT19.09.2018
NO19.12.2018
Former [2019/07]LT19.09.2018
Cited inInternational search[XY]WO2010107825  (PANGU BIOPHARMA LTD [CN], et al) [X] 1-12,14-24,41-48,52-69,71,72,76,77,82-84 * pages 1-9,32,; claim - * * the whole document * [Y] 1-81;
 [XY]WO2011072265  (ATYR PHARMA INC [US], et al) [X] 1-8,14-24,41-48,52-69,71,72,76,77,82-84 * pages 4,37-38; claim -; sequence 28 * * pages 64-65 * [Y] 1-81;
 [XPI]WO2013123432  (ATYR PHARMA INC [US], et al) [XP] 1,63,65,71-86 * the whole document * * pages 87,97; claim - * * page 115 * [I] 2-62,64,66-70;
 [XDPI]US2014066321  (XU ZHIWEN [CN], et al) [XDP] 1,63,65,71-77,81-84 * the whole document * [I] 2-62,64,66-70,78-80,85,86;
 [Y]  - PAUL J CARTER, "Introduction to current and future protein therapeutics: A protein engineering perspective", EXPERIMENTAL CELL RESEARCH, ACADEMIC PRESS, US, vol. 317, no. 9, doi:10.1016/J.YEXCR.2011.02.013, ISSN 0014-4827, (20110224), pages 1261 - 1269, (20110301), XP028205664 [Y] 1-68 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.yexcr.2011.02.013
 [Y]  - HUANG ET AL, "Receptor-Fc fusion therapeutics, traps, and MIMETIBODY technology", CURRENT OPINION IN BIOTECHNOLOGY, LONDON, GB, vol. 20, no. 6, doi:10.1016/J.COPBIO.2009.10.010, ISSN 0958-1669, (20091104), pages 692 - 699, (20091104), XP026778880 [Y] 1-68 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.copbio.2009.10.010
 [Y]  - A. HÄUSSERMANN ET AL, "Das Anti-Jo-1-Syndrom - eine Sonderform der Myositis mit interstitieller Lungenerkrankung", PNEUMOLOGIE, (20100412), vol. 64, no. 08, doi:10.1055/s-0029-1244054, ISSN 0934-8387, pages 496 - 503, XP055131699 [Y] 69-81 * the whole document *

DOI:   http://dx.doi.org/10.1055/s-0029-1244054
 [Y]  - LEVINE STUART M ET AL, "Anti-aminoacyl tRNA synthetase immune responses: Insights into the pathogenesis of the idiopathic inflammatory myopathies", CURRENT OPINION IN RHEUMATOLOGY, CURRENT SCIENCE, LONDON, GB, (20031101), vol. 15, no. 6, ISSN 1040-8711, pages 708 - 713, XP009145406 [Y] 69-81 * the whole document *
 [A]  - GUZZO ET AL, "Systematic analysis of fusion and affinity tags using human aspartyl-tRNA synthetase expressed in E. coli", PROTEIN EXPRESSION AND PURIFICATION, ACADEMIC PRESS, SAN DIEGO, CA, (20070426), vol. 54, no. 1, doi:10.1016/J.PEP.2007.03.001, ISSN 1046-5928, pages 166 - 175, XP022056649 [A] 1-86 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.pep.2007.03.001
ExaminationUS2011086058
by applicantUS3773919
 US4326053
 US4326052
 US4751180
 US4861760
 US4873192
 US4888354
 US4935233
 US5116964
 US5420109
 US5428130
 US5455165
 US5466468
 US5514582
 US5624821
 US5725871
 US5756353
 US5780045
 US5804212
 WO0042072
 US6291212
 US6300099
 US6406697
 US2003118592
 US2003190311
 WO2004016750
 WO2005047337
 US2005255144
 US7029872
 US7030226
 US2006173170
 US2006269553
 US2007092940
 US2007092521
 US7217797
 US2007111281
 US7230068
 US2007148170
 US2007224188
 US2007253966
 US2007269369
 US7326681
 US2008206246
 US7425619
 WO2008147143
 US2009010921
 US2009017023
 US2009163699
 US7629163
 US7632924
 US7638299
 US7662925
 US2010080794
 US2010092997
 US7700321
 US7732570
 US2010143254
 US7737226
 US7736872
 US2010184959
 US2010203046
 US2010209424
 US2010249382
 US2010255013
 US7816320
 US7820766
 US7829310
 US7838265
 US7883866
 US7939496
 US7947473
    - SAMBROOK ET AL., Molecular Cloning: A Laboratory Manual, (2000), vol. I-II
    - DNA Cloning: A Practical Approach
    - Peptide and protein PEGylation, Advanced Drug Delivery Reviews, (2002), vol. 54, pages 453 - 609
    - ZALIPSKY, S. ET AL., "Use of functionalized Poly(Ethylene Glycols) for modification of polypeptides", POLYETHYLENE GLYCOL CHEMISTRY: BIOTECHNICAL AND BIOMEDICAL APPLICATIONS
    - DEVERAUX ET AL., NUCLEIC ACIDS RESEARCH, (1984), vol. 12, pages 387 - 395
    - ALTSCHUL ET AL., NUCL. ACIDS RES., (1997), vol. 25, page 3389
    - NEEDLEMAN; WUNSCH, J. MOL. BIOL., (1970), vol. 48, pages 444 - 453
    - E. MEYERS; W. MILLER, CABIOS, (1989), vol. 4, pages 11 - 17
    - ALTSCHUL ET AL., J. MOL. BIOL, (1990), vol. 215, pages 403 - 10
    - ALTSCHUL ET AL., NUCLEIC ACIDS RES., (1997), vol. 25, pages 3389 - 3402
    - KUNKEL, PROC. NATL. ACAD. SCI. USA., (1985), vol. 82, pages 488 - 492
    - KUNKEL ET AL., METHODS IN ENZYMOL, (1987), vol. 154, pages 367 - 382
    - "A model of evolutionary change in proteins", DAYHOFF ET AL., Matrices for determining distance relationships, NATIONAL BIOMEDICAL RESEARCH FOUNDATION, (1978), vol. 5, pages 345 - 358
    - GONNET ET AL., SCIENCE, (1992), vol. 256, pages 14430 - 1445
    - XU ET AL., STRUCTURE, (2012), vol. 20, pages 1470 - 7
    - ZAIWARA ET AL., MOL BIOTECHNOL., (2012), vol. 51, pages 67 - 102
    - PERONA; HADD, BIOCHEMISTRY, (2012), vol. 51, pages 8705 - 29
    - MORIN ET AL., TRENDS BIOTECHOL., (2011), vol. 29, pages 159 - 66
    - COLLINS ET AL., ANNU. REV. BIOPHYS., (2011), vol. 40, pages 81 - 98
    - WITTMANN ET AL., J VIS EXP., (2012), vol. 65, page E4203
    - FELDMAN ET AL., MOL CELL, (2012), vol. 47, pages 585 - 95
    - CLUTTERBUCK ET AL., J PROTEOMICS, (2011), vol. 74, pages 704 - 15
    - GIDDINGS; MAITRA, J BIOMOL SCREEN, (2010), vol. 15, pages 1204 - 10
    - WIJNHOVEN ET AL., GLYCOCONJ J., (2008), vol. 25, pages 177 - 85
    - FROW ET AL., MED RES REV., (2004), vol. 24, pages 276 - 98
    - ROBERTS; VELLACCIO, The Peptides: Analysis, Synthesis, Biology, ACADEMIC PRESS, INC., (1983), vol. 5, page 341
    - Combinatorial Chemistry, JOHN WILEY & SONS INC., (1997), page 235
    - Burger's Medicinal Chemistry and Drug Discovery, JOHN WILEY & SONS INC., (1995), pages 619 - 620
    - NAKAMURA ET AL., NUC. ACID. RES., (2000), vol. 28, page 292
    - KAMEDA ET AL., BIOCHEM. BIOPHYS. RES. COMMUN., (2006), vol. 349, pages 1269 - 1277
    - ZUKER M., NUCL. ACID RES., (2003), vol. 31, pages 3406 - 3415
    - MANTYH ET AL., PNAS, (1995), vol. 92, pages 2662 - 2666
    - MANTYH ET AL., PROTO EXP. & PURIF., (1995), vol. 6, page 124
    - MERRIFIELD, J. AM. CHEM. SOC., (1963), vol. 85, pages 2149 - 2154
    - BEAUCAGE ET AL., TETRAHEDRON LETTERS, (1981), vol. 22, pages 1859 - 1869
    - MATTHES ET AL., EMBO JOURNAL, (1984), vol. 3, pages 801 - 805
    - STRUCTURAL GENOMICS CONSORTIUM ET AL., NATURE METHODS, (2008), vol. 5, pages 135 - 146
    - SHIMP ET AL., PROTEIN EXPR PURIF., (2006), vol. 50, pages 58 - 67
    - QING ET AL., NATURE BIOTECHNOLOGY, (2004), vol. 22, pages 877 - 882
    - GRANT ET AL., METHODS ENZYMOL., (1987), vol. 153, pages 516 - 544
    - LI ET AL., NATURE BIOTECHNOLOGY, (2006), vol. 24, pages 210 - 215
    - HAMILTON ET AL., SCIENCE, (2003), vol. 301, page 1244
    - HAMILTON ET AL., SCIENCE, (2006), vol. 313, pages 1441 - 1443
    - WILDT ET AL., NATURE REVIEWS MICROBIOL., (2005), vol. 3, pages 119 - 28
    - GERNGROSS ET AL., NATURE-BIOTECHNOLOGY, (2004), vol. 22, pages 1409 - 1414
    - TAKAMATSU, EMBO J., (1987), vol. 6, pages 307 - 311
    - CORUZZI ET AL., EMBO J., (1984), vol. 3, pages 1671 - 1680
    - BROGLIE ET AL., SCIENCE, (1984), vol. 224, pages 838 - 843
    - WINTER ET AL., RESULTS PROBL. CELL DIFFER., (1991), vol. 17, pages 85 - 105
    - HOBBS, Yearbook of Science and Technology, MCGRAW HILL, (1992), pages 191 - 196
    - ENGELHARD ET AL., PNAS USA, (1994), vol. 91, pages 3224 - 3227
    - LOGAN; SHENK, PNAS USA, (1984), vol. 81, pages 3655 - 3659
    - GRAHAM ET AL., J. GEN VIROL., (1977), vol. 36, page 59
    - MATHER, BIOL. REPROD., (1980), vol. 23, pages 243 - 251
    - MATHER ET AL., ANNALS NY. ACAD. SCI., (1982), vol. 383, pages 44 - 68
    - URLAUB ET AL., PNAS USA, (1980), vol. 77, page 4216
    - YAZAKI; WU, Methods in Molecular Biology, HUMANA PRESS, (2003), vol. 248, pages 255 - 268
    - SHIN ET AL., INTERN. REV. IMMUNOL., (1993), vol. 10, pages 177 - 186
    - UMANA ET AL., NAT BIOTECHNOL., (1999), vol. 17, pages 176 - 180
    - DAVIES ET AL., BIOTECHNOL BIOENG., (2001), vol. 74, pages 288 - 294
    - SHIELDS ET AL., J BIOL CHEM., (2002), vol. 277, pages 26733 - 26740
    - SHINKAWA ET AL., J BIOL CHEM., (2003), vol. 278, pages 3466 - 3473
    - SHIELDS ET AL., JBIOL CHEM., (2001), vol. 276, pages 6591 - 6604
    - PRESTA ET AL., BIOCHEM SOC TRANS., (2002), vol. 30, pages 487 - 490
    - ZUCKERMAN ET AL., CRC CRIT REV MICROBIOL., (1978), vol. 7, pages 1 - 26
    - CLYNES ET AL., PNAS, (1998), vol. 95, pages 652 - 656
    - GEORGE; HERINGA, J PROTEIN ENG., (2002), vol. 15, pages 871 - 879
    - MARATEA ET AL., GENE, (1985), vol. 40, pages 39 - 46
    - MURPHY ET AL., PNAS USA, (1986), vol. 83, pages 8258 - 8262
    - LIU ET AL., PNAS, (1997), vol. 94, pages 5525 - 5530
    - KIM ET AL., PNAS, (1996), vol. 93, pages 1156 - 1160
    - CHAUDHARY ET AL., PNAS, (1990), vol. 87, pages 1066 - 1070
    - BIRD ET AL., SCIENCE, (1988), vol. 242, pages 423 - 426
    - DESJARLAIS; BERG, PNAS, (1993), vol. 90, pages 2256 - 2260
    - PNAS, (1994), vol. 91, pages 11099 - 11103
    - DONNELLY ET AL., J. GEN. VIROL., (2001), vol. 82, pages 1027 - 1041
    - DONNELLY ET AL., JOURNAL OF GENERAL VIROLOGY, (2001), vol. 82, pages 1027 - 1041
    - RYAN ET AL., J. GENER. VIROL., (1997), vol. 78, pages 699 - 722
    - SCYMCZAK ET AL., NATURE BIOTECH., (2004), vol. 5, pages 589 - 594
    - MILLER, LM, PATHOLOGY LECTURE NOTES
    - PUFFENBERGER ET AL., PLOS ONE, (2012), vol. 7, no. 1, page E28936
    - PIERCE ET AL., PNAS USA, (2011), vol. 108, no. 16, pages 6543 - 6548
    - HOFFMAN AS, ANN. NY. ACAD. SCI., (2001), vol. 944, pages 62 - 73
    - Remington's Pharmaceutical Sciences, pages 1035 - 1038,157
    - FINNIN; MORGAN, J. PHARM. SCI., (1999), vol. 88, no. 10, pages 955 - 958
    - FICHTNER-FEIGL ET AL., J. CLIN. INVEST., (2005), vol. 115, pages 3057 - 3071
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.